Reduning Injection
Function and Efficacy
1. Pharmacological tests show that this product has antipyretic effect on fever in rats caused by 2,4-nitrophenol and Escherichia coli, and fever in rabbits caused by triple vaccine; it can prolong the average survival time of mice infected with influenza virus, and has a certain effect on reducing the lung index of mice infected with influenza virus; it has a certain effect on reducing the mortality of mice infected with Staphylococcus aureus and Klebsiella pneumoniae; it can inhibit the swelling of the ear of mice caused by xylene; it can increase the serum carbon particle clearance index of mice, increase the serum hemolysin level, and enhance the delayed hypersensitivity reaction of mice caused by sheep red blood cells; it can inhibit the writhing pain reaction of mice caused by acetic acid. 2. Toxicological tests show that rats were intraperitoneally injected with 5.2g, 17.3g, and 41.6g of crude drug/kg/day for 28 consecutive days. It can be seen that GRAN of each administration group decreased, the spleen coefficient of rats in the high-dose group increased, and T-BIL increased; Beagle dogs were intravenously injected with 3.5g, 17.4g, and 30.45g of crude drug/kg/day for 28 consecutive days. The results showed that the liver of dogs in the high-dose group was slightly damaged, and a too fast push injection speed could cause ischemic changes in the electrocardiogram (S-T segment was significantly elevated and T wave fused). In addition, a too fast push injection speed of this product could easily cause salivation, vomiting and other reactions.
Ingredients
Artemisia annua, honeysuckle, gardenia.
Appearance
This product is a light yellow-brown to reddish-brown clear liquid.
Usage and Dosage
Intravenous drip. 1. Adult dose: 20 ml at a time, diluted with 250 ml of 5% glucose injection or 0.9% sodium chloride injection, the drip rate is 30-60 drops per minute, once a day. The treatment course for patients with upper respiratory tract infection is three days, and the treatment course for patients with acute tracheobronchitis is five days; or follow the doctor's advice. 2. Child dose: 3 to 5 years old, the maximum dose does not exceed 10 ml. Dilute with 5% glucose injection or 0.9% sodium chloride injection 50-100mI and drip intravenously. The drip rate is 30-40 drops per minute, once a day; 6 to 10 years old, 10 ml at a time. Dilute with 100-200 ml of 5% glucose injection or 0.9% sodium chloride injection and drip intravenously. The drip rate is 30-60 drops per minute, once a day
Adverse Reactions
1. Some patients may experience dizziness, chest tightness, dry mouth, diarrhea, nausea and vomiting. 2. Occasionally, allergic reactions such as redness, itching or rash may occur.
Precautions
1. Those who are allergic to this product are prohibited from using it. 2. Those with a history of drug allergy should use it with caution.
Special Population Medication
Precautions during pregnancy and lactation: There is no clinical research data on the use of this product in pregnant women.
Drug Interactions
There is no information on the interaction of this product with other drugs.
Storage
Store in a cool place (not exceeding 20°C) away from light.
Packaging Specification
10 ml per bottle
Validity Period
18 months.
Manufacturer
Jiangsu Kanion Pharmaceutical Co., Ltd.
-
Founded in:
1996-05-08 -
Address:
Lianyungang Economic and Technological Development Zone Jiangning Industrial City -
Tax NO.:
91320700138997640W -
Registered Funds:
581.797452 million yuan -
Website:
-
Email: